Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  20 results for ""Drug Hypersensitivity Syndrome""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Fatal outcome related to drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis of FAERS database and a systematic review of cases.

  • Authors : Liang C; Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/mortality

  • Source: Frontiers in immunology [Front Immunol] 2024 Dec 16; Vol. 15, pp. 1490334. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis.

  • Authors : Li W; Department of Pharmacy, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, 315010, Zhejiang, China.; Yu Y

Subjects: Proton Pump Inhibitors*/Proton Pump Inhibitors*/Proton Pump Inhibitors*/adverse effects ; Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/Adverse Drug Reaction Reporting Systems*/statistics & numerical data ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology

  • Source: International journal of clinical pharmacy [Int J Clin Pharm] 2024 Dec; Vol. 46 (6), pp. 1381-1390. Date of Electronic Publication: 2024 Jul 23.Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A Personalized Medicine Approach to Guide Allopurinol Use and Prevent Serious Adverse Events: Ethnicity Is Not a Proxy for Genetics.

  • Authors : Ikediobi O; Department of Dermatology, University of California, San Diego, San Diego, California, USA.

Subjects: Precision Medicine*; Allopurinol/Allopurinol/Allopurinol/*adverse effects ; Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/*genetics

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Oct; Vol. 110 (4), pp. 852-854. Date of Electronic Publication: 2020 Dec 16.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Reporting of drug reaction with eosinophilia and systemic symptoms from 2002 to 2019 in the US Food and Drug Administration Adverse Event Reporting System.

  • Authors : Bluestein SB; Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.; Yu R

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/diagnosis ; Eosinophilia*

  • Source: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Aug; Vol. 9 (8), pp. 3208-3211.e1. Date of Electronic Publication: 2021 May 24.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Editorial & Opinion

Comment on "Viral reactivation in hospitalized DRESS patients: A retrospective study from a tertiary medical center in the United States".

  • Authors : Cho YT; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Yang CW

Subjects: Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/epidemiology ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/etiology

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Sep; Vol. 83 (3), pp. e209-e210. Date of Electronic Publication: 2020 May 13.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Vemurafenib Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Disproportionality Analysis in FAERS Database.

  • Authors : Neha R; Department of Pharmacy Practice, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, India.; Beulah E

Subjects: Adverse Drug Reaction Reporting Systems* ; Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/Drug Hypersensitivity Syndrome*/diagnosis; Databases, Factual

  • Source: Current reviews in clinical and experimental pharmacology [Curr Rev Clin Exp Pharmacol] 2021; Vol. 16 (2), pp. 168-173.Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 9918227368306676 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Editorial & Opinion

Reply to: "Comment on Viral reactivation in hospitalized DRESS patients: A retrospective study from a tertiary medical center in the United States".

  • Authors : Milani-Nejad N; Division of Dermatology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus. Electronic address: .; Trinidad J

Subjects: Drug Hypersensitivity Syndrome* ; Eosinophilia*; Humans

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Sep; Vol. 83 (3), pp. e211. Date of Electronic Publication: 2020 May 13.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Vancomycin-associated drug-induced hypersensitivity syndrome.

  • Authors : Madigan LM; Department of Dermatology, University of Utah, Salt Lake City, Utah.; Fox LP

Subjects: Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/*epidemiology ; Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/*etiology ; Vancomycin/Vancomycin/Vancomycin/*adverse effects

  • Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2019 Jul; Vol. 81 (1), pp. 123-128. Date of Electronic Publication: 2019 Feb 06.Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.

Subjects: United States Food and Drug Administration*; Antipsychotic Agents/Antipsychotic Agents/Antipsychotic Agents/*adverse effects ; Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/Drug Hypersensitivity Syndrome/*epidemiology

  • Source: The Journal of clinical psychiatry [J Clin Psychiatry] 2015 Sep; Vol. 76 (9), pp. e1138-9.Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 7801243 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

DRESS Syndrome and Daclizumab Failure--Were Potentially Dangerous Signs Missed in Clinical Trials?

Subjects: *DRESS syndrome; *ENCEPHALITIS; *CLOTHING & dressUNITED States; SPAIN; GERMANY

  • Source: Drug Target Insights. 2018, Issue 12, p1-2. 2p.

Record details

Read More Add to Saved list
×
  • 1-10 of  20 results for ""Drug Hypersensitivity Syndrome""